{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:08:18Z","timestamp":1794654498336,"version":"4.9.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T00:00:00Z","timestamp":1419206400000},"content-version":"vor","delay-in-days":112,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000550","name":"British Geriatrics Society","doi-asserted-by":"publisher","award":["342"],"award-info":[{"award-number":["342"]}],"id":[{"id":"10.13039\/501100000550","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC Clinician Scientist Fellowship to AMJM","award":["G108\/646"],"award-info":[{"award-number":["G108\/646"]}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"ESRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","award":["MR\/K026992\/1"],"award-info":[{"award-number":["MR\/K026992\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Senior Research Fellowship to CC","award":["SRF 090907"],"award-info":[{"award-number":["SRF 090907"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jpsychores.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jpsychores.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T11:00:37Z","timestamp":1404471637000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Cerebrospinal fluid markers of neuroinflammation in delirium: A role for interleukin-1\u03b2 in delirium after hip fracture"],"prefix":"10.1016","volume":"77","author":[{"given":"Eleanor","family":"Cape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roanna J","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C","family":"van Munster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah EM","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim O","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia E","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-9370","authenticated-orcid":false,"given":"Alasdair MJ","family":"MacLullich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychores.2014.06.014_bb0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bmj.39169.706574.AD","article-title":"Delirium in older people","volume":"334","author":"Young","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neurobiolaging.2010.04.002","article-title":"Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium","volume":"33","author":"Murray","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","article-title":"Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system","volume":"22","author":"Chen","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neurobiolaging.2005.03.010","article-title":"Peripheral infection and aging interact to impair hippocampal memory consolidation","volume":"27","author":"Barrientos","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0025","doi-asserted-by":"crossref","first-page":"15248","DOI":"10.1523\/JNEUROSCI.6361-11.2013","article-title":"Cyclooxygenase-1 dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction","volume":"33","author":"Griffin","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0030","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1532-5415.2008.01851.x","article-title":"Time-course of cytokines during delirium in elderly patients with hip fractures","volume":"56","author":"van Munster","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychores.2006.11.013","article-title":"Cytokines and acute phase response in delirium","volume":"62","author":"de Rooij","year":"2007","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/afp014","article-title":"Cytokines and IGF-1 in delirious and non-delirious acutely ill older medical inpatients","volume":"38","author":"Adamis","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/gps.1265","article-title":"Plasma insulin-like growth factor-1 and incident delirium","volume":"20","author":"Wilson","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0050","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1532-5415.2011.03428.x","article-title":"Cerebrospinal IL-8 levels are higher in hip fracture patients with delirium versus controls","volume":"59","author":"MacLullich","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yfrne.2008.10.001","article-title":"Interleukin-1 (IL-1): a central regulator of stress responses","volume":"30","author":"Goshen","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1476-5381.2008.00129.x","article-title":"Transport of interleukin-1 across cerebromicrovascular endothelial cells","volume":"156","author":"Skinner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(25)20576-6","article-title":"Human interleukin (IL) 1 alpha murine IL-1a and murine IL-1b are transported from blood to brain in the mouse by a shared saturable mechanism","volume":"259","author":"Banks","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0075","doi-asserted-by":"crossref","first-page":"C1513","DOI":"10.1152\/ajpcell.00371.2011","article-title":"Interleukin-ib-induced barrier dysfunction is signaled through pkc-o in human brain microvascular endothelium","volume":"302","author":"Rigor","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0085","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpsychores.2008.05.019","article-title":"Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses","volume":"65","author":"MacLullich","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0100","unstructured":"Association, American Psychiatric: [dsm iv tr], 2000."},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0105","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-113-12-941","article-title":"Clarifying confusion \u2013 the confusion assessment method \u2013 a new method for detection of delirium","volume":"113","author":"Inouye","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1017\/S0033291700005742","article-title":"The informant questionnaire on cognitive decline in the elderly (iqcode) \u2014 socio-demographic correlates, reliability, validity and some norms","volume":"19","author":"Jorm","year":"1989","journal-title":"Psychol Med"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ageing\/26.1.31","article-title":"Cognitive impairment in medical inpatients. I: screening for dementia \u2014 is history better than mental state?","volume":"26","author":"Harwood","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/infdis\/175.3.689","article-title":"Increased levels of interleukin-1b and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis","volume":"175","author":"Mehta","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","article-title":"The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type ii after steroid therapy","volume":"207","author":"Dujmovic","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0135","doi-asserted-by":"crossref","first-page":"12728","DOI":"10.1073\/pnas.1118748109","article-title":"Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice","volume":"109","author":"Lampa","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1468-1331.2009.02609.x","article-title":"Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts","volume":"16","author":"Sun","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002093-199809000-00016","volume":"12","author":"Lanzrein","year":"1998","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jpsychires.2004.12.005","article-title":"Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?","volume":"39","author":"Richartz","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","article-title":"Intracerebral production of tumor necrosis factor-a, a local neuroprotective agent, in Alzheimer disease and vascular dementia","volume":"19","author":"Tarkowski","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0160","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.60.9.1218","article-title":"Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease","volume":"60","author":"Gomez-Tortosa","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2478\/v10039-012-0013-y","article-title":"The diagnostic value of cytokine and nitric oxide concentrations in cerebrospinal fluid for the differential diagnosis of meningitis","volume":"57","author":"Bociaga-Jasik","year":"2012","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10096-009-0708-6","article-title":"Sequential analysis of biomarkers in CSF and serum during invasive meningococcal disease","volume":"28","author":"Beran","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2169\/internalmedicine.43.42","article-title":"Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings","volume":"43","author":"Asaoka","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0180","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer's disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2010.02.017","article-title":"Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation","volume":"473","author":"Kalita","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2000.740457.x","article-title":"\u201cInflammatory\u201d cytokines: neuromodulators in normal brain?","volume":"74","author":"Vitkovic","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0195","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ana.22082","article-title":"Role of interleukin-1 beta in postoperative cognitive dysfunction","volume":"68","author":"Cibelli","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(98)00368-6","article-title":"Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 beta and inducible nitric oxide synthase in rat brain","volume":"89","author":"Konsman","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004647-199901000-00010","article-title":"The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat","volume":"19","author":"Davies","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbi.2009.02.015","article-title":"Il-1\/il-1ra balance in the brain revisited \u2014 evidence from transgenic mouse models","volume":"23","author":"Spulber","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2249.1997.4621483.x","article-title":"Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke","volume":"110","author":"Tarkowski","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0166-2236(00)01661-1","article-title":"Interleukin 1 in the brain: biology, pathology and therapeutic target","volume":"23","author":"Rothwell","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbi.2008.12.008","article-title":"Central inhibition of interleukin-1 beta ameliorates sickness behavior in aged mice","volume":"23","author":"Abraham","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.07.012","article-title":"At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response","volume":"28","author":"Cunningham","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0240","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.neurobiolaging.2007.04.012","article-title":"Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide","volume":"29","author":"Huang","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0245","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0889-1591(02)00077-6","article-title":"Cytokine-induced sickness behavior","volume":"17","author":"Kelley","year":"2003","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-3-33","article-title":"Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls","volume":"3","author":"Pearson","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0255","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and s-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0265","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/bbrc.1997.6436","article-title":"Endogenous interleukin-1 receptor antagonist is neuroprotective","volume":"234","author":"Loddick","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0275","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1196\/annals.1391.022","article-title":"Interleukin-1 system in CNS stress; seizures, fever, and neurotrauma","volume":"1113","author":"Bartfai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0280","author":"Clinical Trials Register E"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/jcbfm.2010.103","article-title":"Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study","volume":"31","author":"Galea","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0290","doi-asserted-by":"crossref","first-page":"R301","DOI":"10.1186\/ar795","article-title":"A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer","volume":"5","author":"Gouze","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0295","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI114622","article-title":"Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist","volume":"85","author":"Arend","year":"1990","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0300","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jocn.2009.08.013","article-title":"Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease","volume":"17","author":"Mashayekhi","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/biof.5520330202","article-title":"Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease","volume":"33","author":"Salehi","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2006.05.008","article-title":"Intrathecal cytokines in spinal cord schistosomiasis","volume":"177","author":"Ferrari","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0315","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.53.5.1104","article-title":"Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases","volume":"53","author":"Fassbender","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0325","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","article-title":"Inflammation in CNS injury","volume":"358","author":"Allan","year":"2003","journal-title":"Philos Trans R Soc Lond B"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0330","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/rej.2011.1185","article-title":"Neuroinflammation in delirium: a postmortem case\u2013control study","volume":"14","author":"van Munster","year":"2011","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0335","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","article-title":"Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis","volume":"258","author":"Axelsson","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0340","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0345","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1227\/NEU.0b013e318214a81f","article-title":"Neuron-specific enolase, s100b, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury","volume":"68","author":"Bohmer","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0350","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1373\/clinchem.2009.134122","article-title":"Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischaemic stroke patients","volume":"56","author":"Brouns","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpsychores.2014.06.014_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A sensitive elisa for glial fibrillary acidic protein: application in CSF of adults","volume":"51","author":"Rosengren","year":"1994","journal-title":"J Neurosci Methods"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399914002487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399914002487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T13:41:36Z","timestamp":1746279696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399914002487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0022399914002487"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2014.06.014","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid markers of neuroinflammation in delirium: A role for interleukin-1\u03b2 in delirium after hip fracture","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2014.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}